Perceived barriers to reporting adverse drug events in hospitals: A qualitative study using theoretical domains framework approach

Implementation Science

Volumn 10, Issue 1, 2015, Pages

  Mirbaha, Fariba ^a   Shalviri, Gloria ^a,b   Yazdizadeh, Bahareh ^a   Gholami, Kheirollah ^c   Majdzadeh, Reza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Food and Drug Organization   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOSPITAL; HOSPITAL PERSONNEL; HUMAN; INFORMATION PROCESSING; IRAN; MOTIVATION; PSYCHOLOGY; QUALITATIVE RESEARCH; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FOCUS GROUPS; HOSPITALS; HUMANS; INTENTION; IRAN; MOTIVATION; PERSONNEL, HOSPITAL; QUALITATIVE RESEARCH;

EID: 84938596195     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-015-0302-5     Document Type: Article

References (41)

1. The Uppsala Monitoring Center. http://www.who-umc.org (2013). Accessed 7 Jan 2015.
2. National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) (2015). http://www.nccmerp.org . Accessed 7 Jan 2015.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279:1200-205.
4. Wester K, Jonsson A, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2007;65(4):573-9.
5. Wester K, Jonsson A, Spigset O, Hagg S. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden. Pharmacoepidemiol Drug Saf. 2007;16(2):173-80.
6. Pal S, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36:75-81.
7. Shalviri G, Valadkhani M, Dinarvand R. Ten years pharmacovigilance activities in Iran. Iran J Public Health. 2009;38 Suppl 1:162-5.
8. Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reactions reporting: a critical and systematic review. Drug Saf. 2013;36:317-28.
9. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998;316(7140):1295-8.
10. Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-8.
11. Agarwal R, Daher AM, Ismail NM. Knowledge, practice and attitude towards adverse drug reaction reporting by private practitioners from Klang Valley in Malaysia. Malays J Med Sci. 2013;20(2):52-61.
12. Pl G, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. RSAP. 2011;7:369-82. doi: 10.1016/j. sapharm. 2010.09.001 . Epub 2010 Nov 5.
13. Ferlie EB, Shortell SM. Improving the quality of health care in the United Kingdom and the United States: a framework for change. Milbank Q. 2001;79(2):281-315.
14. Eccles M, Grimshaw J, Walker A, Johnston M, Pitts N. Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings. J Clin Epidemiol. 2005;58(2):107-12.
15. Improved Clinical Effectiveness through Behavioural Research Group (ICEBeRG). Designing theoretically-informed implementation interventions. Implement Sci. 2006;1:4.
16. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26-33.
17. French SD, Green SE, O'Connor DA, McKenzie JE, Francis JJ, Michie S, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implementation Science. 2012;7:38.
18. Grol RP, Bosch MC, Hulscher ME, Eccles MP, Wensing M. Planning and studying improvement in patient care: the use of theoretical perspectives. Milbank Q. 2007;85(1):93-138.
19. Noar SM, Zimmerman RS. Health behavior theory and cumulative knowledge regarding health behaviors: are we moving in the right direction? Health Educ Res. 2005;20(3):275-90.
20. Lippke S, Ziegelmann JP. Theory-based health behavior change: developing, testing, and applying theories for evidence-based interventions. Appl Psychol. 2008;57(4):698-716.
21. Cane J, O'Connor DA, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.
22. Weinstein ND. Testing four competing theories of health-protective behaviour. Health Psychol. 1993;12:324-33.
23. McKenzie JE, French SD, O'Connor DA, Grimshaw JM, Mortimer D, Michie S, et al. Implementing a clinical practice guideline for acute low back pain evidence-based management in general practice (IMPLEMENT): cluster randomized controlled trial study protocol. Implement Sci. 2008;3:1.
24. Dyson J, Lawton R, Jackson C, Cheater F. Does the use of a theoretical approach tell us more about hand hygiene behaviour? The barriers and levers to hand hygiene. J Infect Prev. 2011;12:17-24.
25. Francis JJ, Stockton C, Eccles MP, Johnston M, Cuthbertson BH, Grimshaw JM, et al. Evidence based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour. Br J Health Psychol. 2009;14:625-46.
26. McCluskey A, Middleton S. Delivering an evidence-based outdoor journey intervention to people with stroke: barriers and enablers experienced by community rehabilitation teams. BMC Health Serv Res. 2010;10:18.
27. Amemori M, Korhonen T, Kinnunen T, Michie S, Murtomaa H. Enhancing implementation of tobacco use prevention and cessation counselling guideline among dental providers: a cluster randomized controlled trial. Implement Sci. 2011;6:13.
28. Patey AM, Islam R, Francis JJ, Bryson GL, Grimshaw JM, Canada PRIME Plus Team. Anesthesiologists' and surgeons' perceptions about routine pre-operative testing in low risk patients: application of the theoretical domains framework (TDF) to identify factors that influence physicians' decisions to order preoperative tests. Implement Sci. 2012;7:52. doi: 10.1186/1748-5908-7-52 .
29. Taylor N, Lawton R, Conner MC. Development and initial validation of the determinants of physical activity questionnaire. Inter J Behav Nutr Physic Act. 2013;10:74. doi: 10.1186/1479-5868-10-74 .
30. Bussieres AE, Patey AM, Francis JJ, Sales AE, Grimshaw JM, Canada PRIME Plus Team. Identifying factors likely to influence compliance with diagnostic imaging guideline recommendations for spine disorders among chiropractors in North America: a focus group study using the theoretical domains framework. Implement Sci. 2012;7(82):1-11. doi: 10.1186/1748-5908-7-82 .
31. McKenzie JE, O'Connor DA, Page MJ, Mortimer D, French SD, Walker BF, et al. Improving the care for people with acute low-back pain by allied health professionals (the ALIGN trial): a cluster randomized trial protocol. Implement Sci. 2010;5:86. doi: 10.1186/1748-5908-5-86 .
32. Wensing M, Bosch M, Grol R. Selecting, tailoring and implementation knowledge translation interventions. In: Straus SE, Tetore J, Graham ID, editors. Knowledge translation in health care: Moving from evidence to practice. London: Blackwell publishing Ltd. BMJ Books; 2009. p. 94-113.
33. Backstrom M, Ekman E, Mjorndal T. Adverse drug reactions reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007;63:613-8.
34. Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan China to the reporting of adverse drug reactions. Chin Med J. 2004;117:856-61.
35. Hanafi H, Torkamandi H, Hayatshahi A, Gholami K, AshrafiShahmirzadi N, Javadi MR. An educational intervention to improve knowledge, attitude and practice toward reporting of adverse drug reactions. Iran J Nurs Midwifery Res. 2014;19(1):101-6.
36. Bäckström M, Mjörndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions-a way of dealing with an old problem. Eur J Clin Pharmacol. 2006;62(5):381-5.
37. Feely J, Moriarty S, O'Connor P. Stimulating reporting of adverse drug reactions by using a fee. Br Med j. 1990;300:22-3.
38. Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009;32(1):77-83. doi: 10.2165/00002018-200932010-00007 .
39. Schlienger RG, Lüscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21(3):110-5.
40. Baniasadi S, Habibi M, Haghgoo R, Karimi G, Amishan M, Dabaghzadeh F, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014;13(1):291-7.
41. Brubacher JR, Hunte GS, Hamilton L, Taylor A. Barriers to and incentives for safety event reporting in emergency departments. Healthc Q. 2011;14(3):57-65.